Gilead Sciences, Inc.
GILD
$118.37
-$0.65-0.55%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 6.31B | 5.97B | 480.00M | 126.00M | 1.05B |
| Total Depreciation and Amortization | 2.77B | 2.77B | 2.77B | 2.76B | 2.76B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.71B | 3.08B | 8.46B | 9.04B | 7.76B |
| Change in Net Operating Assets | -1.92B | -1.45B | -880.00M | -1.91B | -4.10B |
| Cash from Operations | 9.87B | 10.37B | 10.83B | 10.02B | 7.47B |
| Capital Expenditure | -499.00M | -522.00M | -523.00M | -591.00M | -572.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -939.00M | -1.07B | -4.84B | -5.04B | -4.55B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.03B | -65.00M | 1.91B | 1.68B | 1.66B |
| Cash from Investing | -3.47B | -1.66B | -3.45B | -3.95B | -3.47B |
| Total Debt Issued | 3.46B | 3.46B | 3.46B | 1.00M | 1.98B |
| Total Debt Repaid | -1.89B | -3.73B | -1.97B | -1.96B | -4.10B |
| Issuance of Common Stock | 550.00M | 528.00M | 422.00M | 275.00M | 260.00M |
| Repurchase of Common Stock | -1.91B | -1.48B | -1.15B | -950.00M | -950.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.96B | -3.94B | -3.92B | -3.89B | -3.86B |
| Other Financing Activities | -369.00M | -340.00M | -281.00M | -267.00M | -263.00M |
| Cash from Financing | -4.11B | -5.50B | -3.43B | -6.79B | -6.93B |
| Foreign Exchange rate Adjustments | 81.00M | -3.00M | -40.00M | 52.00M | 2.00M |
| Miscellaneous Cash Flow Adjustments | 1.00M | -- | -- | -- | -- |
| Net Change in Cash | 2.37B | 3.21B | 3.91B | -669.00M | -2.93B |